However, NAM treatment effectively ameliorated these conditions and protected neurodegenerative conditions, such as neuroinflammation, apoptosis, and synaptic dysfunction, via the regulation of RAGE/JNK/NF-κB, in an animal model of brain injury. The gene discussed is MAPK8; the disease is injury.